Media Releases

2023

29/09/2023

ASX Health Stocks: Proteomics soars 13pc after US sets price for PromarkerD – The Daily Telegraph

29/09/2023

US price locked in for Proteomics diabetes test – The West Australian

28/09/2023

Proteomics International Laboratories Ltd PromarkerD US Reimbursement Price & Aus Regulatory Decision – MarketScreener

27/09/2023

Proteomics develops new blood test for esophageal cancer – BioWorld

14/09/2023

Early diagnosis a step closer for those at risk of oesophageal cancer – BiotechDispatch

14/09/2023

Early detection for oesophageal cancer – Medical Forum

14/09/2023

Early Oesophageal Cancer Diagnosis Now Closer for At-Risk – Mirage News

10/09/2023

Proteomics International Laboratories Ltd (ASX:PIQ) New Oesophageal Cancer Test Presented At Global Conference – Menafn

08/09/2023

Proteomics International (ASX:PIQ) to present new oesophageal cancer test at global conference – The Market Herald

08/09/2023

Proteomics blood test primed for cancer fight – The West Australian

04/09/2023

Proteomics International Laboratories Ltd OxiDx Platform Technology Secures Patent in Japan – The West Australian

15/06/2023

Intervention needed to stop kidney disease overwhelming NHS, Kidney Research UK says – Evening Standard

14/06/2023

NHS facing ‘impossible’ challenge to care for kidney disease patients, Kidney Research UK warns – itv

11/06/2023

Kidney disease ‘could become public health emergency’ without more funding, charity warns – sky news

06/06/2023

New Kidney Research UK Report Shows Kidney Disease is a Public Health Emergency

1
2
3
4
5
6
7
8
9
…
25